+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 180 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5516254
Description Jump to:
The global RNA analysis market size is expected to reach USD 20.21 billion by 2030, registering a CAGR of 10.86% according to this report.. Transcriptomics is one of the most advanced fields in the post-genomic period. Technological advancements in this industry can be attributed to the increasing applications of transcriptome sequencing in life science for capturing polyadenylated RNA. With the expansion of next-generation high-throughput sequencing technology, the analysis of transcriptomes has been gradually improving the understanding of the regulatory network of RNA-based genes. For instance, in July 2021, the Lithuanian team is developing a droplet-based technique for simultaneous mRNA and microRNA capture and sequencing in a single cell.

The research is backed by the European Union with a USD174,000 Horizon 2020 research grant. Moreover, in May 2022, CD Genomics launched the Digital RNA sequencing technology, which is an NGS-based method that excludes sequence-dependent PCR. Such initiatives are anticipated to accelerate market growth shortly. Ribonucleic acid transcriptome analysis enables the researchers to analyze the position of genes as well as the functional patterns of a specific gene in an organism. The method assists in evaluating every transcript’s changing behavior at the development stage and assesses all the elements of a transcript, including messenger ribonucleic acid, non-coding ribonucleic acid, and micro ribonucleic acid, for identifying the transcriptional structure of genes.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Furthermore, increasing demand for personalized medicines is anticipated to fuel the industry growth during the forecast period. In April 2020, Caris Life Sciences announced the submission of Pre-Market Approval applications for MI Transcriptome CDx to the USFDA. It is a powerful precision medicine assay, which contains significant companion diagnostic biomarkers. On the other hand, data management in transcriptomic research and the lack of effective bioinformatics tools are some of the major challenges in the industry.

The evolution of high-throughput technologies has provided invaluable opportunities for generating holistic views of complex biological processes. Despite the considerable availability of omics data, the conversation of biological data into clinically valuable knowledge remains one of the major challenges. It is not only because of insufficient current data processing or integration methods but also for inappropriate application of existing analysis approaches. North America has been reported as the highest revenue-generating region in 2021 owing to increasing investments in pharmaceutical and biotechnology research by corporations. Asia Pacific is projected to register the fastest CAGR from 2022 to 2030 owing to the low-cost manufacturing services.

RNA Analysis Market Report Highlights

  • Real-Time- PCR (qPCR) accounted for the major market share in the technology segment in 2022 and is said to continue the trend during the forecast period owing to the increasing use of PCR for COVID-19 diagnostic across the globe
  • The transcriptome sequencing technology is estimated to register a significant CAGR during the forecast period owing to factors, such as advancements in sequencing technology and growing acceptance of NGS technology
  • The kits and reagents segment accounted for the highest revenue share in 2022 owing to a high utilization rate of consumables during transcriptomic studies
  • The infectious diseases and pathogenesis segment accounted for the largest share in 2022 and is anticipated to have a similar trend during the forecasted period
  • The increasing prevalence of the infectious disease is the major factor driving the segment growth
  • Government institutes & academic centers dominated the end-user segment as the increasing number of institutes and centers leveraged high throughput technologies for the effective and efficient process of ribonucleic acid analysis

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
3.2.1.2. Rising Diagnostic Utility Of Transcriptomics Technologies
3.2.1.3. Advent of Novel Approaches for Understanding Gene Expression at RNA Level
3.2.2. Market Restraint Analysis
3.2.2.1. Higher Cost of Research & Developments
3.2.2.2. High Costs Associated With Analysis Platforms
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. RNA Analysis Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Kits & Reagents
4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
4.3.2. miRNA & siRNA
4.3.2.1. miRNA & siRNA Market, 2018 - 2030 (USD Million)
4.3.3. Reverse Transcriptases & RT-PCR
4.3.3.1. Reverse Transcriptases & RT-PCR Market, 2018 - 2030 (USD Million)
4.3.4. RNA Extraction & Purification
4.3.4.1. RNA Extraction & Purification Market, 2018 - 2030 (USD Million)
4.3.5. RNA Interference
4.3.5.1. RNA Interference Market, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Other Kits & Reagents Market, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. RNA Analysis Market: Technology Movement Analysis
5.2. Real Time-PCR (qPCR)
5.2.1. Real Time-PCR (qPCR) Market, 2018 - 2030 (USD Million)
5.3. Microarray
5.3.1. Microarray Market, 2018 - 2030 (USD Million)
5.4. Sequencing
5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. RNA Analysis Market: Application Movement Analysis
6.2. Construction of RNA Expression Atlas
6.2.1. Construction of RNA Expression Atlas Market, 2018 - 2030 (USD Million)
6.3. Epigenetics
6.3.1. Epigenetics Market, 2018 - 2030 (USD Million)
6.4. Infectious Diseases & Pathogenesis
6.4.1. Infectious Diseases & Pathogenesis Market, 2018 - 2030 (USD Million)
6.5. Alternative RNA Splicing
6.5.1. Alternative RNA Splicing Market, 2018 - 2030 (USD Million)
6.6. RNA Structure & Molecular Dynamics
6.6.1. RNA Structure & Molecular Dynamics Market, 2018 - 2030 (USD Million)
6.7. Development & Delivery of RNA Therapeutics
6.7.1. Development & Delivery of RNA Therapeutics Market, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Government Institutes & Academic Centers
7.1.1. Government Institutes & Academic Centers Market, 2018 - 2030 (USD Million)
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
7.4. Contract Research Organizations (CROs)
7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. RNA Analysis Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America RNA Analysis Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Target Disease Prevalence
8.2.2.3. Competitive Scenario
8.2.2.4. U.S. RNA Analysis Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Canada RNA Analysis Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. UK RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Germany RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. France RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Italy RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Spain RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Denmark RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Sweden RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Norway RNA Analysis Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Japan RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. China RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. India RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Australia RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Thailand RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. South Korea RNA Analysis Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America RNA Analysis Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Brazil RNA Analysis Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Mexico RNA Analysis Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Argentina RNA Analysis Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. South Africa RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Saudi Arabia RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. UAE RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Kuwait RNA Analysis Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Agilent Technologies, Inc
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. F. Hoffmann-La Roche AG
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Illumina, Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. QIAGEN
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Thermo Fisher Scientific, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Eurofins Scientific
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Merck KGaA
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Bio-Rad Laboratories, Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Pacific Bioscience of California, Inc.;
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Affymetrix, Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Danaher
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Promega
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
List of Tables
Table 1: List of secondary sources
Table 2: Global RNA analysis market, by product, 2018-2030 (USD Million)
Table 3: Global RNA analysis market, by technology, 2018-2030 (USD Million)
Table 4: Global RNA analysis market, by application, 2018-2030 (USD Million)
Table 5: Global RNA analysis market, by end-use, 2018-2030 (USD Million)
Table 6: Global RNA analysis market, by region, 2018-2030 (USD Million)
Table 7: North America RNA analysis market by product, 2018-2030 (USD Million)
Table 8: North America RNA analysis market by technology, 2018-2030 (USD Million)
Table 9: North America RNA analysis market by application, 2018-2030 (USD Million)
Table 10: North America RNA analysis market by end-use, 2018-2030 (USD Million)
Table 11: U.S. RNA analysis market by product, 2018-2030 (USD Million)
Table 12: U.S. RNA analysis market by technology, 2018-2030 (USD Million)
Table 13: U.S. RNA analysis market by application, 2018-2030 (USD Million)
Table 14: U.S. RNA analysis market by end-use, 2018-2030 (USD Million)
Table 15: Canada RNA analysis market by product, 2018-2030 (USD Million)
Table 16: Canada RNA analysis market by technology, 2018-2030 (USD Million)
Table 17: Canada RNA analysis market by application, 2018-2030 (USD Million)
Table 18: Canada RNA analysis market by end-use, 2018-2030 (USD Million)
Table 19: Europe RNA analysis market by product, 2018-2030 (USD Million)
Table 20: Europe RNA analysis market by technology, 2018-2030 (USD Million)
Table 21: Europe RNA analysis market by application, 2018-2030 (USD Million)
Table 22: Europe RNA analysis market by end-use, 2018-2030 (USD Million)
Table 23: Germany RNA analysis market by product, 2018-2030 (USD Million)
Table 24: Germany RNA analysis market by technology, 2018-2030 (USD Million)
Table 25: Germany RNA analysis market by application, 2018-2030 (USD Million)
Table 26: Germany RNA analysis market by end-use, 2018-2030 (USD Million)
Table 27: U.K. RNA analysis market by product, 2018-2030 (USD Million)
Table 28: U.K. RNA analysis market by technology, 2018-2030 (USD Million)
Table 29: U.K. RNA analysis market by application, 2018-2030 (USD Million)
Table 30: U.K. RNA analysis market by end-use, 2018-2030 (USD Million)
Table 31: France RNA analysis market by product, 2018-2030 (USD Million)
Table 32: France RNA analysis market by technology, 2018-2030 (USD Million)
Table 33: France RNA analysis market by application, 2018-2030 (USD Million)
Table 34: France RNA analysis market by end-use, 2018-2030 (USD Million)
Table 35: Italy RNA analysis market by product, 2018-2030 (USD Million)
Table 36: Italy RNA analysis market by technology, 2018-2030 (USD Million)
Table 37: Italy RNA analysis market by application, 2018-2030 (USD Million)
Table 38: Italy RNA analysis market by end-use, 2018-2030 (USD Million)
Table 39: Spain RNA analysis market by product, 2018-2030 (USD Million)
Table 40: Spain RNA analysis market by technology, 2018-2030 (USD Million)
Table 41: Spain RNA analysis market by application, 2018-2030 (USD Million)
Table 42: Spain RNA analysis market by end-use, 2018-2030 (USD Million)
Table 43: Denmark RNA analysis market by product, 2018-2030 (USD Million)
Table 44: Denmark RNA analysis market by technology, 2018-2030 (USD Million)
Table 45: Denmark RNA analysis market by application, 2018-2030 (USD Million)
Table 46: Denmark RNA analysis market by end-use, 2018-2030 (USD Million)
Table 47: Sweden RNA analysis market by product, 2018-2030 (USD Million)
Table 48: Sweden RNA analysis market by technology, 2018-2030 (USD Million)
Table 49: Sweden RNA analysis market by application, 2018-2030 (USD Million)
Table 50: Sweden RNA analysis market by end-use, 2018-2030 (USD Million)
Table 51: Norway RNA analysis market by product, 2018-2030 (USD Million)
Table 52: Norway RNA analysis market by technology, 2018-2030 (USD Million)
Table 53: Norway RNA analysis market by application, 2018-2030 (USD Million)
Table 54: Norway RNA analysis market by end-use, 2018-2030 (USD Million)
Table 55: Asia Pacific RNA analysis market by product, 2018-2030 (USD Million)
Table 56: Asia Pacific RNA analysis market by technology, 2018-2030 (USD Million)
Table 57: Asia Pacific RNA analysis market by application, 2018-2030 (USD Million)
Table 58: Asia Pacific RNA analysis market by end-use, 2018-2030 (USD Million)
Table 59: China RNA analysis market by product, 2018-2030 (USD Million)
Table 60: China RNA analysis market by technology, 2018-2030 (USD Million)
Table 61: China RNA analysis market by application, 2018-2030 (USD Million)
Table 62: China RNA analysis market by end-use, 2018-2030 (USD Million)
Table 63: Japan RNA analysis market by product, 2018-2030 (USD Million)
Table 64: Japan RNA analysis market by technology, 2018-2030 (USD Million)
Table 65: Japan RNA analysis market by application, 2018-2030 (USD Million)
Table 66: Japan RNA analysis market by end-use, 2018-2030 (USD Million)
Table 67: India RNA analysis market by product, 2018-2030 (USD Million)
Table 68: India RNA analysis market by technology, 2018-2030 (USD Million)
Table 69: India RNA analysis market by application, 2018-2030 (USD Million)
Table 70: India RNA analysis market by end-use, 2018-2030 (USD Million)
Table 71: Australia RNA analysis market by product, 2018-2030 (USD Million)
Table 72: Australia RNA analysis market by technology, 2018-2030 (USD Million)
Table 73: Australia RNA analysis market by application, 2018-2030 (USD Million)
Table 74: Australia RNA analysis market by end-use, 2018-2030 (USD Million)
Table 75: Thailand RNA analysis market by product, 2018-2030 (USD Million)
Table 76: Thailand RNA analysis market by technology, 2018-2030 (USD Million)
Table 77: Thailand RNA analysis market by application, 2018-2030 (USD Million)
Table 78: Thailand RNA analysis market by end-use, 2018-2030 (USD Million)
Table 79: South Korea RNA analysis market by product, 2018-2030 (USD Million)
Table 80: South Korea RNA analysis market by technology, 2018-2030 (USD Million)
Table 81: South Korea RNA analysis market by application, 2018-2030 (USD Million)
Table 82: South Korea RNA analysis market by end-use, 2018-2030 (USD Million)
Table 83: Latin America RNA analysis market by product, 2018-2030 (USD Million)
Table 84: Latin America RNA analysis market by technology, 2018-2030 (USD Million)
Table 85: Latin America RNA analysis market by application, 2018-2030 (USD Million)
Table 86: Latin America RNA analysis market by end-use, 2018-2030 (USD Million)
Table 87: Brazil RNA analysis market by product, 2018-2030 (USD Million)
Table 88: Brazil RNA analysis market by technology, 2018-2030 (USD Million)
Table 89: Brazil RNA analysis market by application, 2018-2030 (USD Million)
Table 90: Brazil RNA analysis market by end-use, 2018-2030 (USD Million)
Table 91: Mexico RNA analysis market by product, 2018-2030 (USD Million)
Table 92: Mexico RNA analysis market by technology, 2018-2030 (USD Million)
Table 93: Mexico RNA analysis market by application, 2018-2030 (USD Million)
Table 94: Mexico RNA analysis market by end-use, 2018-2030 (USD Million)
Table 95: Argentina RNA analysis market by product, 2018-2030 (USD Million)
Table 96: Argentina RNA analysis market by technology, 2018-2030 (USD Million)
Table 97: Argentina RNA analysis market by application, 2018-2030 (USD Million)
Table 98: Argentina RNA analysis market by end-use, 2018-2030 (USD Million)
Table 99: MEA RNA analysis market by product, 2018-2030 (USD Million)
Table 100: MEA RNA analysis market by technology, 2018-2030 (USD Million)
Table 101: MEA RNA analysis market by application, 2018-2030 (USD Million)
Table 102: MEA RNA analysis market by end-use, 2018-2030 (USD Million)
Table 103: South Africa RNA analysis market by product, 2018-2030 (USD Million)
Table 104: South Africa RNA analysis market by technology, 2018-2030 (USD Million)
Table 105: South Africa RNA analysis market by application, 2018-2030 (USD Million)
Table 106: South Africa RNA analysis market by end-use, 2018-2030 (USD Million)
Table 107: Saudi Arabia RNA analysis market by product, 2018-2030 (USD Million)
Table 108: Saudi Arabia RNA analysis market by technology, 2018-2030 (USD Million)
Table 109: Saudi Arabia RNA analysis market by application, 2018-2030 (USD Million)
Table 110: Saudi Arabia RNA analysis market by end-use, 2018-2030 (USD Million)
Table 111: UAE RNA analysis market by product, 2018-2030 (USD Million)
Table 112: UAE RNA analysis market by technology, 2018-2030 (USD Million)
Table 113: UAE RNA analysis market by application, 2018-2030 (USD Million)
Table 114: UAE RNA analysis market by end-use, 2018-2030 (USD Million)
Table 115: Kuwait RNA analysis market by product, 2018-2030 (USD Million)
Table 116: Kuwait RNA analysis market by technology, 2018-2030 (USD Million)
Table 117: Kuwait RNA analysis market by application, 2018-2030 (USD Million)
Table 118: Kuwait RNA analysis market by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value chain-based sizing & forecasting
Fig. 6: Market formulation & validation
Fig. 7: RNA analysis market segmentation
Fig. 8: Market snapshot, 2022
Fig. 9: Market trends & outlook
Fig. 10: Market driver relevance analysis (current & future impact)
Fig. 11: Market restraint relevance analysis (current & future impact)
Fig. 12: PESTEL analysis
Fig. 13: Porter’s five forces analysis
Fig. 14: RNA analysis market: Products outlook and key takeaways
Fig. 15: RNA analysis market: Product movement analysis
Fig. 16: Instruments market estimates and forecast, 2018-2030 (USD Million)
Fig. 17: Kits & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 18: miRNA and siRNA market estimates and forecast, 2018-2030 (USD Million)
Fig. 19: Reverse transcriptase & RT-PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 20: RNA extraction & purification market estimates and forecast, 2018-2030 (USD Million)
Fig. 21: RNA interference market estimates and forecast, 2018-2030 (USD Million)
Fig. 22: Others kits & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 23: Services market estimates and forecast, 2018-2030 (USD Million)
Fig. 24: RNA analysis market: Technology outlook and key takeaways
Fig. 25: RNA analysis market: Technology movement analysis
Fig. 26: Real time-PCR (qPCR) market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Microarray market estimates and forecast, 2018-2030 (USD Million)
Fig. 28: Sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 29: Other technologies market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: RNA analysis market: Application outlook and key takeaways
Fig. 31: RNA analysis Market: Application movement analysis
Fig. 32: Construction of RNA expression atlas market estimates and forecast, 2018-2030 (USD Million)
Fig. 33: Epigenetics market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Infectious diseases and pathogenesis market estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Alternative RNA splicing market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: RNA structure and molecular dynamics market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Development and delivery of RNA therapeutics market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: Others applications market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: RNA analysis market: End-use outlook and key takeaways
Fig. 40: RNA analysis market: End-use movement analysis
Fig. 41: Government institutes & academic centers estimates and forecast, 2018-2030 (USD Million)
Fig. 42: Pharmaceutical & biotechnology companies estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Hospitals & clinics estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Contract Research Organizations (CROs) estimates and forecast, 2018-2030 (USD Million)
Fig. 45: RNA analysis market: Regional outlook and key takeaways
Fig. 46: RNA analysis market: Regional movement analysis
Fig. 47: North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 52: U.K. market estimates and forecast, 2018-2030 (USD Million)
Fig. 53: France market estimates and forecast, 2018-2030 (USD Million)
Fig. 54: Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 55: Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 56: Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 57: Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 58: Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 59: Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 61: China market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: India market estimates and forecast, 2018-2030 (USD Million)
Fig. 63: Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 65: South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 66: Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 67: Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 68: Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 69: Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 70: MEA market estimates and forecast, 2018-2030 (USD Million)
Fig. 71: South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 72: Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 73: UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 74: Kuwait market estimates and forecast, 2018-2030 (USD Million)

Companies Mentioned

  • Agilent Technologies, Inc
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Pacific Bioscience of California, Inc.;
  • Affymetrix, Inc.
  • Danaher
  • Promeg

Methodology

Loading
LOADING...

Related Topics

Related Reports

gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type (Research-Use), Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type (Research-Use), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Antisense And RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Genetic), By Route of Administration (Intrathecal, Intravenous), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Antisense And RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Genetic), By Route of Administration (Intrathecal, Intravenous), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 130 Pages
  • Global
From
RNA Therapy Market by Technology, Indication, End User - Global Forecast 2025-2030 - Product Image

RNA Therapy Market by Technology, Indication, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
RNA Interference Technology Market by Type, Therapeutics, Application - Global Forecast 2025-2030 - Product Image

RNA Interference Technology Market by Type, Therapeutics, Application - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
RNA Analysis / Transcriptomics - Global Strategic Business Report - Product Image

RNA Analysis / Transcriptomics - Global Strategic Business Report

  • Report
  • 504 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.